Buy Genocea Biosciences Stock | GNCA Stock Price & Latest News | Public.com
GNCA

Genocea Biosciences

$0.00 (0.00%)Today
    Small Market Cap
    View Genocea Biosciences (GNCA) stock trends here

    About GNCA

    Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. It uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include G...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.13
    -0.26
    -0.39
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.19

    Actual EPS
    Q1 2021

    Stats

    Market Cap$162,69M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.75
    1 Year Low$1.10
    Open$3.10
    High$3.19
    Low$3.03

    Buy any stock with any amount of money.

    Download the App
    Download the app